Cyclophosphamide, Fludarabine [clinicaltrials_resource:11e837efe61162dcd961c16dcf6c1349]
intervention [clinicaltrials_vocabulary:intervention]
Cyclophosphamide, Fludarabine [clinicaltrials_resource:11e837efe61162dcd961c16dcf6c1349]
Bio2RDF identifier
11e837efe61162dcd961c16dcf6c1349
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:11e837efe61162dcd961c16dcf6c1349
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Day -5 through Day -2, subject ...... lophosphamide via central line
intervention name [clinicaltrials_vocabulary:intervention-name]
Cyclophosphamide, Fludarabine
other name [clinicaltrials_vocabulary:other-name]
Cytoxan, Fludara
identifier
clinicaltrials_resource:11e837efe61162dcd961c16dcf6c1349
title
Cyclophosphamide, Fludarabine
@en
type
label
Cyclophosphamide, Fludarabine [clinicaltrials_resource:11e837efe61162dcd961c16dcf6c1349]
@en